Drugs & Targets StrataNGS genomic profiling receives Medicare coverage in patients with advanced solid tumors October 30, 2020Vol.46 No.41
Drugs & Targets FoundationOne Liquid CDx companion diagnostic receives FDA approval in indications for targeted therapies in ovarian, breast and NSCLC October 30, 2020Vol.46 No.41
Drugs & Targets Venclexta combination receives FDA approval for untreated AML October 23, 2020Vol.46 No.40
Drugs & Targets Tagrisso receives FDA Priority Review for adjuvant treatment of early-stage EGFR-mutated lung cancer October 23, 2020Vol.46 No.40
Drugs & Targets Keytruda receives FDA approvals in Hodgkin lymphoma indications October 16, 2020Vol.46 No.39
Drugs & Targets MD Anderson and Allogene Therapeutics collaborate to advance allogeneic CAR T therapy October 16, 2020Vol.46 No.39
Drugs & TargetsFree Opdivo + Yervoy receive FDA approval in mesothelioma indication October 09, 2020Vol.46 No.38
Drugs & TargetsFree Regeneron asks FDA for emergency clearance for COVID-19 therapy October 09, 2020Vol.46 No.38
Drugs & TargetsFree FDA issues draft guidance that encourages inclusion of premenopausal women in breast cancer clinical trials October 09, 2020Vol.46 No.38
